Clinical Trial Update: Daratumumab in Treating Patients With Multiple Myeloma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update of daratumumab in patients with plasma cell myeloma (Multiple Myeloma) completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma
• Plasma Cell Myeloma

Drugs mentioned

• Daratumumab (daratumumab)

Snippet

Sponsor: Ohio State University Comprehensive Cancer Center | Conditions: Plasma Cell Myeloma | Phase 2 | Status: COMPLETED | Results posted: 2019-09-09